Drug Pipeline

KITE-753 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-04 NCT04989803
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell…		 Trial sites expanded: 18 -> 21 locations
Active Studies by Phase
Phase 3
1
Phase 1/2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07479797 Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants… Relapsed or Refractory Large B-cell Lymphoma Recruiting
Phase 1/2
NCT04989803 Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell… Relapsed and/or Refractory B-cell Lymphoma Recruiting
Not specified
NCT05041309 Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies… Solid and Hematological Malignancies Enrolling by Invitation
Sponsors Running KITE-753 Trials
Kite, A Gilead Company (3)
Get alerts when KITE-753 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free